Keywords: merck, co, strikes, 272m, development, deal, actelion

Merck & Co strikes $272M development deal with Actelion

Article | 15 December 2003

Print This

US drug major Merck & Co has entered into an agreement with Swissbiotechnology firm Actelion in a bid to beef up ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in